United Therapeutics Current Ratio 2012-2026 | UTHR

Current and historical current ratio for United Therapeutics (UTHR) from 2012 to 2026. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. United Therapeutics current ratio for the three months ending March 31, 2026 was 0.00.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
United Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2026-03-31 $3.47B $0.81B 4.27
2025-12-31 $3.70B $0.56B 6.61
2025-09-30 $3.49B $0.55B 6.40
2025-06-30 $3.83B $0.53B 7.26
2025-03-31 $3.94B $0.72B 5.46
2024-12-31 $3.87B $0.74B 5.25
2024-09-30 $4.00B $0.87B 4.58
2024-06-30 $3.62B $0.83B 4.35
2024-03-31 $3.25B $0.86B 3.78
2023-12-31 $3.55B $0.80B 4.41
2023-09-30 $3.46B $0.74B 4.65
2023-06-30 $3.21B $0.37B 8.68
2023-03-31 $3.19B $0.33B 9.84
2022-12-31 $3.38B $0.34B 9.85
2022-09-30 $3.06B $0.32B 9.68
2022-06-30 $2.68B $0.33B 8.10
2022-03-31 $2.59B $0.29B 8.84
2021-12-31 $2.32B $0.31B 7.61
2021-09-30 $2.39B $0.32B 7.46
2021-06-30 $2.32B $0.31B 7.44
2021-03-31 $2.01B $0.30B 6.66
2020-12-31 $2.17B $0.32B 6.70
2020-09-30 $1.87B $0.26B 7.22
2020-06-30 $1.89B $0.26B 7.43
2020-03-31 $1.85B $0.21B 8.91
2019-12-31 $1.87B $0.46B 4.03
2019-09-30 $1.93B $0.47B 4.11
2019-06-30 $2.14B $0.46B 4.62
2019-03-31 $1.94B $0.27B 7.19
2018-12-31 $1.77B $0.28B 6.39
2018-09-30 $1.61B $0.37B 4.32
2018-06-30 $1.62B $0.35B 4.64
2018-03-31 $1.63B $0.32B 5.13
2017-12-31 $1.45B $0.45B 3.26
2017-09-30 $1.64B $0.79B 2.08
2017-06-30 $1.56B $0.84B 1.86
2017-03-31 $1.50B $0.43B 3.52
2016-12-31 $1.43B $0.33B 4.29
2016-09-30 $1.39B $0.32B 4.41
2016-06-30 $1.32B $0.29B 4.50
2016-03-31 $1.30B $0.36B 3.64
2015-12-31 $1.28B $0.44B 2.89
2015-09-30 $1.23B $0.56B 2.20
2015-06-30 $0.83B $0.54B 1.53
2015-03-31 $0.99B $0.65B 1.54
2014-12-31 $0.96B $0.50B 1.90
2014-09-30 $1.08B $0.76B 1.42
2014-06-30 $0.88B $0.66B 1.34
2014-03-31 $0.99B $0.66B 1.50
2013-12-31 $0.91B $0.69B 1.33
2013-09-30 $0.93B $0.47B 1.99
2013-06-30 $0.90B $0.41B 2.19
2013-03-31 $0.85B $0.18B 4.78
2012-12-31 $0.67B $0.18B 3.78
2012-09-30 $0.72B $0.23B 3.16
2012-06-30 $0.57B $0.19B 3.04
2012-03-31 $0.57B $0.18B 3.27
2011-12-31 $0.56B $0.21B 2.65
2011-09-30 $0.85B $0.43B 1.99
2011-06-30 $0.88B $0.45B 1.94
2011-03-31 $0.81B $0.44B 1.84
2010-12-31 $0.76B $0.43B 1.78
2010-09-30 $0.60B $0.40B 1.51
2010-06-30 $0.52B $0.37B 1.41
2010-03-31 $0.40B $0.33B 1.21
2009-12-31 $0.33B $0.33B 0.98
2009-09-30 $0.32B $0.30B 1.07
2009-06-30 $0.29B $0.08B 3.78
2009-03-31 $0.27B $0.06B 4.47
2008-12-31 $0.30B $0.06B 5.16
2008-09-30 $0.30B $0.29B 1.01
2008-06-30 $0.28B $0.29B 0.96
2008-03-31 $0.33B $0.06B 5.42
2007-12-31 $0.35B $0.27B 1.29
2007-09-30 $0.29B $0.03B 8.75
2007-06-30 $0.25B $0.02B 10.59
2007-03-31 $0.22B $0.02B 11.39
2006-12-31 $0.28B $0.02B 14.41
2006-09-30 $0.18B $0.02B 9.01
2006-06-30 $0.21B $0.02B 8.69
2006-03-31 $0.19B $0.02B 10.54
2005-12-31 $0.17B $0.02B 11.48
2005-09-30 $0.15B $0.02B 8.58
2005-06-30 $0.13B $0.02B 8.04
2005-03-31 $0.12B $0.01B 10.01
2004-12-31 $0.11B $0.01B 7.97
2004-09-30 $0.11B $0.01B 7.61
2004-06-30 $0.10B $0.01B 8.44
2004-03-31 $0.09B $0.01B 8.99
2003-12-31 $0.09B $0.01B 8.45
2003-09-30 $0.11B $0.02B 6.04
2003-06-30 $0.11B $0.01B 8.92
2003-03-31 $0.11B $0.01B 9.98
2002-12-31 $0.14B $0.01B 15.24
2002-09-30 $0.16B $0.01B 15.84
2002-06-30 $0.17B $0.01B 15.35
2002-03-31 $0.08B $0.01B 9.76
2001-12-31 $0.07B $0.01B 6.39
2001-09-30 $0.11B $0.01B 11.17
2001-06-30 $0.17B $0.01B 14.45
2001-03-31 $0.20B $0.01B 16.30
2000-12-31 $0.22B $0.01B 19.33
2000-09-30 $0.24B $0.01B 30.52
2000-06-30 $0.11B $0.01B 16.46
2000-03-31 $0.12B $0.01B 23.56
1999-12-31 $0.05B $0.01B 11.52
1999-09-30 $0.06B $0.00B 26.10
1999-06-30 $0.06B $0.00B 62.78
1999-03-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $25.058B $3.183B
United Therapeutics Corporation markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, an injectable formulation of treprostinil, Orenitram, an oral version of treprostinil, Tyvaso, an inhaled version of treprostinil, and Adcirca (tadalafil; also sold by Eli Lilly as Cialis for erectile dysfunction) tablets.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $89.845B 31.38
UCB SA (UCBJY) Belgium $60.713B 0.00
Takeda Pharmaceutical (TAK) Japan $57.538B 11.30
Zoetis (ZTS) United States $49.577B 18.36
Sandoz Group AG (SDZNY) Switzerland $37.136B 0.00
Otsuka Holdings, - (OTSKY) Japan $36.393B 14.73
BeOne Medicines - (ONC) Switzerland $33.976B 83.02
Daiichi Sankyo, - (DSNKY) Japan $33.284B 16.12
Astellas Pharma (ALPMY) Japan $29.805B 11.68
Shionogi (SGIOY) Japan $18.069B 13.97
Merck (MKKGY) Germany $16.944B 11.65
IPSEN (IPSEY) France $16.273B 0.00
Summit Therapeutics (SMMT) United States $15.264B 0.00
Neurocrine Biosciences (NBIX) United States $12.936B 27.96
Ionis Pharmaceuticals (IONS) United States $12.417B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.920B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.749B 16.23
Orion OYJ (ORINY) Finland $10.723B 18.62
Eisai (ESAIY) $9.158B 0.00
Ono Pharmaceutical (OPHLF) Japan $6.834B 16.35
Centessa Pharmaceuticals (CNTA) United Kingdom $6.102B 0.00
Grifols, S.A (GRFS) Spain $5.588B 0.00
Corcept Therapeutics (CORT) United States $4.458B 51.11
Crinetics Pharmaceuticals (CRNX) United States $4.130B 0.00
Stevanato Group S.p.A (STVN) Italy $4.094B 22.53
NewAmsterdam Pharma (NAMS) Netherlands $3.997B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.945B 16.50
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $3.838B 0.00
Indivior Pharmaceuticals (INDV) United States $3.724B 12.41
Hypermarcas (HYPMY) Brazil $3.308B 13.82
Dyne Therapeutics (DYN) United States $3.086B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.046B 9.86
Oruka Therapeutics (ORKA) United States $2.952B 0.00
Soleno Therapeutics (SLNO) United States $2.717B 228.83
Enliven Therapeutics (ELVN) United States $2.710B 0.00
Relay Therapeutics (RLAY) United States $2.670B 0.00
Guardian Pharmacy Services (GRDN) United States $2.479B 41.65
BioCryst Pharmaceuticals (BCRX) United States $2.398B 7.19
Nektar Therapeutics (NKTR) United States $2.223B 0.00
Definium Therapeutics (DFTX) United States $2.147B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.113B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.096B 19.46
Ocular Therapeutix (OCUL) United States $1.914B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.808B 0.00
Ardelyx (ARDX) United States $1.516B 0.00
Harrow (HROW) United States $1.338B 79.84
Savara (SVRA) United States $1.158B 0.00
Collegium Pharmaceutical (COLL) United States $1.149B 5.37
Xeris Biopharma Holdings (XERS) United States $1.009B 0.00
KalVista Pharmaceuticals (KALV) United States $0.993B 0.00
Cronos Group (CRON) Canada $0.971B 0.00
Evotec AG (EVO) Germany $0.935B 0.00
Xencor (XNCR) United States $0.911B 0.00
Aktis Oncology (AKTS) United States $0.901B 0.00
Theravance Biopharma (TBPH) United States $0.842B 21.80
ARS Pharmaceuticals (SPRY) United States $0.799B 0.00
Relmada Therapeutics (RLMD) United States $0.765B 0.00
Bioventus (BVS) United States $0.753B 13.32
Ironwood Pharmaceuticals (IRWD) United States $0.592B 15.78
ProKidney (PROK) United States $0.589B 0.00
Esperion Therapeutics (ESPR) United States $0.557B 0.00
Zevra Therapeutics (ZVRA) United States $0.556B 9.19
Rigel Pharmaceuticals (RIGL) United States $0.540B 4.49
Lyell Immunopharma (LYEL) United States $0.522B 0.00
Larimar Therapeutics (LRMR) United States $0.504B 0.00
4D Molecular Therapeutics (FDMT) United States $0.501B 0.00
Aquestive Therapeutics (AQST) United States $0.498B 0.00
Aclaris Therapeutics (ACRS) United States $0.487B 0.00
Nature's Sunshine Products (NATR) United States $0.471B 21.37
Lexeo Therapeutics (LXEO) United States $0.443B 0.00
Altimmune (ALT) United States $0.422B 0.00
Elite Pharmaceuticals (ELTP) United States $0.409B 37.99
Century Therapeutics (IPSC) United States $0.404B 0.00
Akebia Therapeutics (AKBA) United States $0.375B 0.00
USANA Health Sciences (USNA) United States $0.334B 9.43
AleAnna (ANNA) United States $0.333B 124.75
Surrozen (SRZN) United States $0.324B 0.00
Siga Technologies (SIGA) United States $0.312B 14.06
Avalo Therapeutics (AVTX) United States $0.311B 0.00
Organogenesis (ORGO) United States $0.306B 8.81
Silence Therapeutics (SLN) United Kingdom $0.271B 0.00
Cybin (HELP) Canada $0.270B 0.00
Protara Therapeutics (TARA) United States $0.268B 0.00
Prelude Therapeutics (PRLD) United States $0.257B 0.00
Minerva Neurosciences (NERV) United States $0.238B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.230B 0.00
MediWound (MDWD) Israel $0.229B 0.00
Context Therapeutics (CNTX) United States $0.229B 0.00
Enlivex (ENLV) Israel $0.228B 0.00
Inhibikase Therapeutics (IKT) United States $0.224B 0.00
Profound Medical (PROF) Canada $0.216B 0.00
OmniAb (OABI) United States $0.213B 0.00
Achieve Life Sciences (ACHV) Canada $0.186B 0.00
Korro Bio (KRRO) United States $0.183B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.174B 0.00
Unicycive Therapeutics (UNCY) United States $0.167B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.167B 0.00
Heron Therapeutics (HRTX) United States $0.161B 0.00
Cardiol Therapeutics (CRDL) Canada $0.154B 0.00
Avita Medical (RCEL) United States $0.154B 0.00
VAXART, INC (VXRT) United States $0.152B 10.50
Galectin Therapeutics (GALT) United States $0.151B 0.00
Karyopharm Therapeutics (KPTI) United States $0.147B 0.00
Journey Medical (DERM) United States $0.141B 0.00
Assertio Holdings (ASRT) United States $0.116B 0.00
Innate Pharma SA (IPHYF) France $0.115B 0.00
Aldeyra Therapeutics (ALDX) United States $0.107B 0.00
Pyxis Oncology (PYXS) United States $0.107B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Vivani Medical (VANI) United States $0.088B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.088B 0.00
PolyPid (PYPD) Israel $0.082B 0.00
Nuo Therapeutics (AURX) $0.082B 0.00
Champions Oncology (CSBR) United States $0.080B 0.00
Gain Therapeutics (GANX) United States $0.076B 0.00
NRx Pharmaceuticals (NRXP) United States $0.073B 0.00
Fractyl Health (GUTS) United States $0.073B 0.00
PMV Pharmaceuticals (PMVP) United States $0.070B 0.00
Rafael Holdings (RFL) United States $0.066B 0.00
Dominari Holdings (DOMH) United States $0.065B 0.00
Acrivon Therapeutics (ACRV) United States $0.060B 0.00
ElectroCore (ECOR) United States $0.049B 0.00
Nutriband (NTRB) United States $0.047B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.046B 34.33
SCYNEXIS (SCYX) United States $0.045B 0.00
Lite Strategy (LITS) United States $0.042B 0.00
Telomir Pharmaceuticals (TELO) United States $0.042B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Talphera (TLPH) United States $0.038B 0.00
Incannex Healthcare (IXHL) Australia $0.037B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Plus Therapeutics (PSTV) United States $0.033B 0.00
Tempest Therapeutics (TPST) United States $0.029B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.029B 0.00
TherapeuticsMD (TXMD) United States $0.024B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Klotho Neurosciences (KLTO) United States $0.016B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Vyome Holdings (HIND) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
Jupiter Neurosciences (JUNS) United States $0.014B 0.00
Wellgistics Health (WGRX) United States $0.014B 0.00
Phio Pharmaceuticals (PHIO) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Traws Pharma (TRAW) United States $0.012B 0.02
Ainos (AIMD) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.011B 0.00
Mannatech (MTEX) United States $0.011B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.011B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
BioVie (BIVI) United States $0.010B 0.00
BioLineRx (BLRX) Israel $0.010B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Liminatus Pharma (LIMN) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Inotiv (NOTV) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Heatwurx (PCSA) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Biomerica (BMRA) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Ernexa Therapeutics (ERNA) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
CDT Equity (CDT) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00